Matthew Spector
Clinical trials sponsored by Matthew Spector, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Nerve wrap aims to ease shoulder pain after neck cancer surgery Results expected Jan 2027 (estimated)
- Glow-in-the-Dark dye could save voices in thyroid surgery Results expected Aug 2027 (estimated)
-
Could immunotherapy spare throat cancer patients from losing their voice?
Disease control Recruiting nowThis phase 2 trial is testing whether adding the immunotherapy drug toripalimab to standard chemotherapy can help people with advanced laryngeal or hypopharyngeal cancer avoid having their voice box removed. The study will enroll 87 adults whose cancer has not been treated before…
Phase 2 • Sponsor: Matthew Spector • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Glowing dye during surgery could prevent dangerous throat leaks
Disease control Recruiting nowThis study tests whether using a fluorescent dye and a special camera during throat surgery can help surgeons see and remove tissue with poor blood flow. Poor blood flow can lead to a leak called a pharyngocutaneous fistula, a serious complication. The trial will enroll 225 adult…
Phase 2 • Sponsor: Matthew Spector • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Glow-in-the-Dark dye could save voices in thyroid surgery
Symptom relief Recruiting nowThis phase 2 trial tests a dye called bevonescein that makes nerves glow during thyroid surgery, helping surgeons see and avoid them. Forty adults having thyroid removal will receive the dye before surgery. The main goal is to see if it improves voice outcomes by reducing nerve i…
Phase 2 • Sponsor: Matthew Spector • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC